Impact of Age on Use of Neoadjuvant Chemoimmunotherapy and Outcomes for Patients with Triple-Negative Breast Cancer.
Study type and data source Multicenter retrospective cohort study using the U.S. National Cancer Database, including 5...
Establishing an Evidence-based Modern Breast MRI Program.
- Post category:Breast Cancer
- Reading time:2 mins read
This review article describes how breast MRI has progressed into a central tool in breast imaging and examines how proto...
Neoadjuvant pembrolizumab plus chemotherapy in older patients with early-stage triple-negative breast cancer: real-world insights from neo-real/GBECAM-0123.
- Post category:Breast Cancer
- Reading time:1 min read
This multicenter real-world study from Brazil and Argentina assessed the KEYNOTE-522 neoadjuvant chemo-immunotherapy reg...
Comparing the Efficacy of Various Treatment Strategies for Patients With Advanced Triple-Negative Breast Cancer: An Umbrella Review.
- Post category:Breast Cancer
- Reading time:2 mins read
This publication is an umbrella review synthesizing evidence from 17 meta-analyses and 52 randomized clinical trials com...
Tucatinib Gives PFS Boost for Metastatic Breast Cancer.
- Post category:Breast Cancer
- Reading time:1 min read
This report describes a phase III study in HER2‑positive metastatic breast cancer evaluating tucatinib added to trastu...
Trimester of diagnosis affects tumor characteristics and survival in breast cancer during pregnancy: first results from the STURGATE collaboration.
- Post category:Breast Cancer
- Reading time:1 min read
This pooled, retrospective analysis combined national cohorts from Sweden and the Netherlands to compare breast cancer d...